Home > Healthcare > Pharmaceuticals > Finished Drug Form > Tramadol Drug Market

Tramadol Drug Market Size

  • Report ID: GMI6684
  • Published Date: Sep 2023
  • Report Format: PDF

Tramadol Drug Market Size

Tramadol Drug Market size was valued to be USD 4.5 billion in 2022 and is expected to reach USD 8.6 billion in 2032, growing at a CAGR of 6.8% from 2023 to 2032. The market's significant growth is primarily driven by the rising prevalence of pain disorders such as arthritis, neuropathy, or fibromyalgia.

 

For instance, according to the Good Body stats, at least 10% of the world’s population is affected by chronic pain, and it has been estimated that 1 in every 5 adults suffer from pain and some acute pains which are undiagnosed till it becomes chronic. Similarly, increase in geriatric population coupled with rise in lower back pain which requires surgery, therapy, and pain management drugs is also boosting the market. Moreover, growing healthcare infrastructure in emerging markets, rising awareness pertaining to pain management, and increasing R&D activities are expected to fuel the market’s growth during the forecast period.

 

Tramadol is a drug used to relieve moderate to severe pain. It belongs to a class of drugs known as opioid analgesics or opioids. It works by binding to opioid receptors in the brain and spinal cord, which helps to alter the way the body perceives and responds to pain. It is used to manage various types of pain, such as

post-surgical pain, chronic pain associated with conditions like osteoarthritis or neuropathy, and pain from injuries.

 

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Tramadol drug market size was USD 4.5 billion in 2022 and will reach USD 8.6 billion by 2032 due to the rising prevalence of pain disorders, such as arthritis, neuropathy, or fibromyalgia worldwide.

The tablet dosage form segment held 50% share of the tramadol drug industry in 2022 and will witness significant growth from 2023-2032 on account of the precise dosage control of tablets that to allow foroffer consistent and accurate administration of tramadol.

North America recorded 38.6% share of the tramadol drug industry in 2022 and is expected to incur appreciable growth from 2023-2032 owing to the prevalence of pain conditions, including acute and chronic pain among consumers in the region.

Zydus Cadila, Purdue Pharma, Mankind Pharma Ltd, Mundipharma, Amneal Pharmaceuticals, Par Pharmaceuticals, Vertical Pharmaceuticals, Grunenthal Group, and Nippon Shinyaku Co., Ltd. are some of the major tramadol drug companies worldwide.

Tramadol Drug Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 9
  • Tables & Figures: 206
  • Countries covered: 19
  • Pages: 120
 Download Free Sample